Cite
MLA Citation
Victor M Oguoma et al.. “10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial.” BMJ open, vol. 10, no. 5, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100135160459.0x000007